Page 18 - Revista Científica Biofar
P. 18
16
1 6 B I O F A R – C I E N T I F I C A
BIOFAR – CIENTIFICA
respiratory tract infections. J Antimicrob dissemination of carbapenem-
Chemother. 2006.57: 1220-2. hydrolysing OXA - 58 - producing
7. Coelho J., Woodford N., Afzal-Shah M. Acinetobacter baumannii isolates in
et al. Occurrence of OXA-58-like Bolivia. J Med Microbiol. 2011.61:80-4.
carbapenemases in Acinetobacter spp. 16. Fernández-Colón E. Identificación y
collected over 10 years in three caracterización genética de la
continents. Antimicrob Agents carbapenemasa OXA-58 en aislamientos
Chemother. 2006.50: 756-8. clínicos de Acinetobacter baumannii
8. Poirel, L., Naas, T. & Nordmann, P. resistentes a imipenem procedentes de
Diversity, epidemiology and genetics of hospitales de Cochabamba, Bolivia.
class D ß- lactamases. Antimicrob Facultad de Medicina y Odontología de
Agents Chemother. 2010. 54,24-38. la Universidad del País Vasco. 2013.
9. Queenan A.M., Bush K. 17. Sevillano E., Moreno M., Funes F.,
Carbapenemases: The versatile beta- Espinoza M., Bustamante Z., Gallego L.
lactamases. Clin Microbiol Rev. First detection of the bla OXA-23 gene in
2007.20: 440-458. a multidrug-resistant A. baumannii
10. Higgins P.G., Poirel L., Lehmann M. et al. clinical isolate from Cochabamba,
OXA-143, a novel carbapenem- Bolivia. J Infect Dev Ctries 2016;
hydrolyzing class D beta-lactamase in 10(11): 1271-1274.
Acinetobacter baumannii. Antimicrob 18. Gallego L., Canduela M.J., Sevillano E.
Agents Chemother. 2009.53: 5035-8. et al. Carbapenemase detection in a
11. Corvec S., Poirel L., Naas T. et al. Acinetobacter baumannii clones resistant
Genetics and expression of the to imipenem. Enferm Infecc Microbiol
carbapenem-hydrolyzing oxacillinase Clin. 2004.22: 262-6.
gene bla OXA-23 in Acinetobacter 19. Higgins P.G., Lehmann M., Wisplinghoff
baumannii. Antimicrob Agents H. et al. gyrB multiplex PCR to
Chemother. 2007.51: 1530-3. differentiate between Acinetobacter
12. Mugnier P.D., Poirel L., Nordmann P. calcoaceticus and Acinetobacter
Functional analysis of insertion sequence genomic species 3. J Clin Microbiol.
ISAba1, responsible for genomic 2010.48: 4592-4.
plasticity of Acinetobacter baumannii. J 20. CLSI. Clinical and laboratory standars
Bacteriol. 2009.191: 2414-8. institute CLSI. 2007. (http://enews.clsi.
13. Gales A.C., Castanheira M., Jones R.N. org/clsi/issues/ 2007-02-01/6.html).
et al. Antimicrobial resistance among 21. Bhargava N., Sharma P., Capalash N.
gram-negative bacilli isolated from Latin Quorum sensing in Acinetobacter: An
America: Results from SENTRY emerging pathogen. Crit Rev Microbiol.
antimicrobial surveillance program 2010.36: 349-60.
(Latin America, 2008-2010). Diagn 22. Bonnin R.A., Nordmann P., Potron A. et
Microbiol Infect Dis. 2012.73: 354-60. al. Carbapenem-hydrolyzing GES-type
14. Fernández E., Bustamante Z., Zamora J., extended-spectrum beta-lactamase in
Zabalaga S, Pinto J., Funes F., Sevillano Acinetobacter baumannii. Antimicrob
E., Umaran A., Gallego L. Determinación Agents Chemother. 2011.55: 349-54.
de carbapenemasas y su relación con 23. Turton J.F., Kaufmann M.E., Warner M.
estructuras genéticas en aislamientos et al. A prevalent, multiresistant clone of
clínicos de Acinetobacter baumannii de Acinetobacter baumannii in Southeast
hospitales de la ciudad de Cochabamba. England. J Hosp Infect. 2004.58: 170-9.
BIOFARBO. 2009.17: 30-38. 24. Tenover F.C., Arbeit R.D., Goering R.V.
15. Sevillano E., Fernández E., Bustamante et al. Interpreting chromosomal DNA
Z. et al. Emergence and clonal restriction patterns produced by pulsed-
